Theresa Greco is Chief Commercial Officer of OptimizeRx Corp. Currently has a direct ownership of 35,345 shares of OPRX, which is worth approximately $156,224. The most recent transaction as insider was on Nov 01, 2024, when has been sold 1,693 shares (Common Stock) at a price of $5.15 per share, resulting in proceeds of $8,718. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.3K
4.57% 3M change
4.57% 12M change
Total Value Held $156,224

Theresa Greco Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2024
SELL
Payment of exercise price or tax liability
$8,718 $5.15 p/Share
1,693 Reduced 4.57%
35,345 Common Stock
Nov 01 2023
BUY
Grant, award, or other acquisition
-
18,519 Added 33.33%
37,038 Common Stock
TG

Theresa Greco

Chief Commercial Officer
Waltham, MA

Track Institutional and Insider Activities on OPRX

Follow OptimizeRx Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OPRX shares.

Notify only if

Insider Trading

Get notified when an Optimize Rx Corp insider buys or sells OPRX shares.

Notify only if

News

Receive news related to OptimizeRx Corp

Track Activities on OPRX